NL0 logo

GRAIL DB:NL0 Stock Report

Last Price

€12.30

Market Cap

€388.8m

7D

2.5%

1Y

n/a

Updated

01 Nov, 2024

Data

Company Financials +

GRAIL, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GRAIL
Historical stock prices
Current Share PriceUS$12.30
52 Week HighUS$19.30
52 Week LowUS$11.10
Beta0
11 Month Change6.03%
3 Month Change-19.08%
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO0%

Recent News & Updates

Recent updates

Shareholder Returns

NL0DE BiotechsDE Market
7D2.5%-0.4%-1.8%
1Yn/a-14.9%13.2%

Return vs Industry: Insufficient data to determine how NL0 performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how NL0 performed against the German Market.

Price Volatility

Is NL0's price volatile compared to industry and market?
NL0 volatility
NL0 Average Weekly Movement9.4%
Biotechs Industry Average Movement6.4%
Market Average Movement5.0%
10% most volatile stocks in DE Market11.5%
10% least volatile stocks in DE Market2.4%

Stable Share Price: NL0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine NL0's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20151,360Bob Ragusagrail.com

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests.

GRAIL, Inc. Fundamentals Summary

How do GRAIL's earnings and revenue compare to its market cap?
NL0 fundamental statistics
Market cap€388.81m
Earnings (TTM)-€2.66b
Revenue (TTM)€101.27m

3.8x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NL0 income statement (TTM)
RevenueUS$109.74m
Cost of RevenueUS$195.28m
Gross Profit-US$85.54m
Other ExpensesUS$2.80b
Earnings-US$2.88b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 12, 2024

Earnings per share (EPS)-92.86
Gross Margin-77.95%
Net Profit Margin-2,627.35%
Debt/Equity Ratio0%

How did NL0 perform over the long term?

See historical performance and comparison